Zhen Li
Vermogen: 117 M $ op 30-09-2026
Vermogen: 117 M $ op 30-09-2026
Dr. Zhen Li is a President, Chief Executive Officer & Director at ADARx Pharmaceuticals, Inc. She is on the Board of Directors at ADARx Pharmaceuticals, Inc.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 25-09-2026 | 5.861.199 ( 5,49% ) | 117 M $ | 30-09-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ADARX PHARMACEUTICALS, INC. | Oprichter | 01-12-2019 |
| Bedrijven | Functie | Einde |
|---|---|---|
| MERCK & CO., INC. | Directeur/Bestuurslid | - |
| ARROWHEAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drugs to treat intractable diseases | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Peking University
Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ADARx Pharmaceuticals, Inc.
ADARx Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops siRNA therapeutics to treat diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau